177 related articles for article (PubMed ID: 25957189)
1. Insights into the mechanisms underlying the antitumor activity of an oxidovanadium(IV) compound with the antioxidant naringenin. Albumin binding studies.
Islas MS; Naso LG; Lezama L; Valcarcel M; Salado C; Roura-Ferrer M; Ferrer EG; Williams PA
J Inorg Biochem; 2015 Aug; 149():12-24. PubMed ID: 25957189
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant, anticancer activities and mechanistic studies of the flavone glycoside diosmin and its oxidovanadium(IV) complex. Interactions with bovine serum albumin.
Naso L; Martínez VR; Lezama L; Salado C; Valcarcel M; Ferrer EG; Williams PAM
Bioorg Med Chem; 2016 Sep; 24(18):4108-4119. PubMed ID: 27374881
[TBL] [Abstract][Full Text] [Related]
3. Bovine serum albumin binding, antioxidant and anticancer properties of an oxidovanadium(IV) complex with luteolin.
Naso LG; Lezama L; Valcarcel M; Salado C; Villacé P; Kortazar D; Ferrer EG; Williams PA
J Inorg Biochem; 2016 Apr; 157():80-93. PubMed ID: 26828287
[TBL] [Abstract][Full Text] [Related]
4. Biological evaluation of new nickel(II) metallates: Synthesis, DNA/protein binding and mitochondrial mediated apoptosis in human lung cancer cells (A549) via ROS hypergeneration and depletion of cellular antioxidant pool.
Kalaivani P; Saranya S; Poornima P; Prabhakaran R; Dallemer F; Vijaya Padma V; Natarajan K
Eur J Med Chem; 2014 Jul; 82():584-99. PubMed ID: 24946146
[TBL] [Abstract][Full Text] [Related]
5. Biological evaluation of morin and its new oxovanadium(IV) complex as antioxidant and specific anti-cancer agents.
Naso LG; Lezama L; Rojo T; Etcheverry SB; Valcarcel M; Roura M; Salado C; Ferrer EG; Williams PA
Chem Biol Interact; 2013 Nov; 206(2):289-301. PubMed ID: 24125835
[TBL] [Abstract][Full Text] [Related]
6. Promising antioxidant and anticancer (human breast cancer) oxidovanadium(IV) complex of chlorogenic acid. Synthesis, characterization and spectroscopic examination on the transport mechanism with bovine serum albumin.
Naso LG; Valcarcel M; Roura-Ferrer M; Kortazar D; Salado C; Lezama L; Rojo T; González-Baró AC; Williams PA; Ferrer EG
J Inorg Biochem; 2014 Jun; 135():86-99. PubMed ID: 24681549
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant and anticancer effects and bioavailability studies of the flavonoid baicalin and its oxidovanadium(IV) complex.
Martínez Medina JJ; Naso LG; Pérez AL; Rizzi A; Ferrer EG; Williams PAM
J Inorg Biochem; 2017 Jan; 166():150-161. PubMed ID: 27863301
[TBL] [Abstract][Full Text] [Related]
9. Study on the cytotoxic, antimetastatic and albumin binding properties of the oxidovanadium(IV) chrysin complex. Structural elucidation by computational methodologies.
Naso LG; Martínez Medina JJ; Okulik NB; Ferrer EG; Williams PAM
Chem Biol Interact; 2022 Jan; 351():109750. PubMed ID: 34813780
[TBL] [Abstract][Full Text] [Related]
10. Copper(II) cation and bathophenanthroline coordination enhance therapeutic effects of naringenin against lung tumor cells.
Caro-Ramírez JY; Rivas MG; Gonzalez PJ; Williams PAM; Naso LG; Ferrer EG
Biometals; 2022 Oct; 35(5):1059-1076. PubMed ID: 35931942
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
Kumar SP; Birundha K; Kaveri K; Devi KT
Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
[TBL] [Abstract][Full Text] [Related]
12. Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction.
Banerjee A; Dash SP; Mohanty M; Sanna D; Sciortino G; Ugone V; Garribba E; Reuter H; Kaminsky W; Dinda R
J Inorg Biochem; 2019 Oct; 199():110786. PubMed ID: 31377474
[TBL] [Abstract][Full Text] [Related]
13. Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells.
Kowalski S; Tesmar A; Sikorski A; Inkielewicz-Stępniak I
Anticancer Agents Med Chem; 2021; 21(1):71-83. PubMed ID: 32579508
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and spectroscopic characterization study of new palladium complexes containing bioactive O,O-chelated ligands: evaluation of the DNA/protein BSA interaction, in vitro antitumoural activity and molecular docking.
Karami K; Mehri Lighvan Z; Farrokhpour H; Dehdashti Jahromi M; Momtazi-Borojeni AA
J Biomol Struct Dyn; 2018 Oct; 36(13):3324-3340. PubMed ID: 29019431
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives.
Latif AD; Gonda T; Vágvölgyi M; Kúsz N; Kulmány Á; Ocsovszki I; Zomborszki ZP; Zupkó I; Hunyadi A
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052551
[TBL] [Abstract][Full Text] [Related]
16. Chiral ruthenium complexes induce apoptosis of tumor cell and interact with bovine serum albumin.
Yuan F; Chen X; Liu Y; Zhang T; Sun D; Liu J
Chirality; 2012 Feb; 24(2):174-80. PubMed ID: 22180296
[TBL] [Abstract][Full Text] [Related]
17. A mononuclear Cu(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: Synthesis, crystal structure, DNA- and BSA-binding, molecular modeling, and anticancer activity against MCF-7, A-549, and HT-29 cell lines.
Anjomshoa M; Hadadzadeh H; Torkzadeh-Mahani M; Fatemi SJ; Adeli-Sardou M; Rudbari HA; Nardo VM
Eur J Med Chem; 2015; 96():66-82. PubMed ID: 25874332
[TBL] [Abstract][Full Text] [Related]
18. In vitro apoptosis-induction, antiproliferative and BSA binding studies of a oxidovanadium(V) complex.
Kongot M; Dohare N; Reddy DS; Pereira N; Patel R; Subramanian M; Kumar A
J Trace Elem Med Biol; 2019 Jan; 51():176-190. PubMed ID: 30466929
[TBL] [Abstract][Full Text] [Related]
19. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial toxicity and antioxidant activity of a prenylated flavonoid isolated from Dalea elegans.
Elingold I; Isollabella MP; Casanova MB; Celentano AM; Pérez C; Cabrera JL; Diez RA; Dubin M
Chem Biol Interact; 2008 Feb; 171(3):294-305. PubMed ID: 18078919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
